From: What can we offer to 3 million MDRTB household contacts in 2016?
Name of trial | Location | Population | Intervention and comparator | Months of treatment/follow-up | Clinical trials registry # |
---|---|---|---|---|---|
TB CHAMP | South Africa | Children <5 years | Levofloxacin vs. placebo | 6/18 | - |
PHOENix | ACTG sites | All contacts (Adults and children) | Delamanid vs. isoniazid | 6/22 | - |
V-QUIN | Vietnam | All contacts (Adults and children) | Levofloxacin vs. placebo | 6/30 | ACTRN12616000215426 |